Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 18971615)

1.

[In vitro amphotericin B susceptibility of korean bloodstream yeast isolates assessed by the CLSI broth microdilution method, Etest, and Minimum fungicidal concentration test].

Park JY, Shin JH, Uh Y, Kim EC, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW.

Korean J Lab Med. 2008 Oct;28(5):346-52. doi: 10.3343/kjlm.2008.28.5.346. Korean.

2.

Biliary amphotericin B pharmacokinetics and pharmacodynamics in critically ill liver transplant recipients receiving treatment with amphotericin B lipid formulations.

Welte R, Eschertzhuber S, Weiler S, Leitner-Rupprich S, Aigner M, Lass-Flörl C, Stienecke E, Bellmann-Weiler R, Joannidis M, Bellmann R.

Int J Antimicrob Agents. 2015 Jun 2. pii: S0924-8579(15)00184-3. doi: 10.1016/j.ijantimicag.2015.04.009. [Epub ahead of print]

PMID:
26119497
3.

β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin.

Franiczek R, Gleńsk M, Krzyżanowska B, Włodarczyk M.

Med Mycol. 2015 Jun 19. pii: myv035. [Epub ahead of print]

PMID:
26092104
4.

Etest cannot be recommended for in vitro susceptibility testing of mucorales.

Caramalho R, Maurer E, Binder U, Araújo R, Dolatabadi S, Lass-Flörl C, Lackner M.

Antimicrob Agents Chemother. 2015 Jun;59(6):3663-5. doi: 10.1128/AAC.00004-15. Epub 2015 Apr 6.

PMID:
25845881
5.

Ecdysteroids in Sida tuberculata R.E. Fries (Malvaceae): chemical composition by LC-ESI-MS and selective anti-Candida krusei activity.

da Rosa HS, de Camargo VB, Camargo G, Garcia CV, Fuentefria AM, Mendez AS.

Food Chem. 2015 Sep 1;182:193-9. doi: 10.1016/j.foodchem.2015.02.144. Epub 2015 Mar 6.

PMID:
25842327
7.

Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage.

Won EJ, Shin JH, Choi MJ, Lee WG, Park YJ, Uh Y, Kim SY, Lee MK, Kim SH, Shin MG, Suh SP, Ryang DW.

PLoS One. 2015 Feb 23;10(2):e0118770. doi: 10.1371/journal.pone.0118770. eCollection 2015.

8.

A diterpenoid taxodone from Metasequoia glyptostroboides with antimycotic potential against clinical isolates of Candida species.

Bajpai VK, Park YH, Kang SC.

J Mycol Med. 2015 Mar;25(1):e31-8. doi: 10.1016/j.mycmed.2014.10.017. Epub 2014 Nov 4.

PMID:
25637428
9.

In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.

Iatta R, Immediato D, Montagna MT, Otranto D, Cafarchia C.

Med Mycol. 2015 Apr 1;53(3):269-74. doi: 10.1093/mmy/myu089. Epub 2015 Jan 28.

PMID:
25631480
10.

Phenotypic switching of Candida guilliermondii is associated with pseudohyphae formation and antifungal resistance.

Lastauskienė E, Čeputytė J, Girkontaitė I, Zinkevičienė A.

Mycopathologia. 2015 Apr;179(3-4):205-11. doi: 10.1007/s11046-014-9844-3. Epub 2014 Dec 7.

PMID:
25481846
11.

Pimenta pseudocaryophyllus inhibits virulence factors and promotes metabolic changes in Candida yeast.

El Assal FE, Paula JA, Capeletti LS, Abrão FY, Ataídes FS, Sá FA, Costa CR, Fernandes Ode F, Souza LK, Silva Mdo R.

Rev Soc Bras Med Trop. 2014 Sep-Oct;47(5):618-23.

12.

Susceptibility profiles of amphotericin B and posaconazole against clinically relevant mucorales species under hypoxic conditions.

Maurer E, Binder U, Sparber M, Lackner M, Caramalho R, Lass-Flörl C.

Antimicrob Agents Chemother. 2015 Feb;59(2):1344-6. doi: 10.1128/AAC.04424-14. Epub 2014 Dec 1.

PMID:
25451049
13.

Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.

Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, de Camargo ZP, Nucci M, Lopes-Bezerra LM, Ishida K, Rozental S.

Med Mycol. 2015 Feb 1;53(2):178-88. doi: 10.1093/mmy/myu056. Epub 2014 Nov 13.

PMID:
25394542
14.

Elevated Staphylococcus ceftriaxone MICs are an Etest artifact.

Limbago BM, Pierce VM, Lonsway DR, Ferraro MJ.

Clin Infect Dis. 2015 Jan 1;60(1):162-3. doi: 10.1093/cid/ciu743. Epub 2014 Sep 28. No abstract available.

PMID:
25266286
15.

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates.

Montagna MT, Lovero G, Coretti C, De Giglio O, Martinelli D, Bedini A, Delia M, Rosato A, Codeluppi M, Caggiano G.

J Med Microbiol. 2014 Dec;63(Pt 12):1638-43. doi: 10.1099/jmm.0.075507-0. Epub 2014 Sep 10.

16.

In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections.

Iatta R, Figueredo LA, Montagna MT, Otranto D, Cafarchia C.

J Med Microbiol. 2014 Nov;63(Pt 11):1467-73. doi: 10.1099/jmm.0.078709-0. Epub 2014 Aug 28.

PMID:
25168965
17.

Invasive mycosis due to species of Blastobotrys in immunocompromised patients with reduced susceptibility to antifungals.

Kumar A, Babu R, Bijulal S, Abraham M, Sasidharan P, Kathuria S, Sharma C, Meis JF, Chowdhary A.

J Clin Microbiol. 2014 Nov;52(11):4094-9. doi: 10.1128/JCM.01977-14. Epub 2014 Aug 27.

18.

The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Mesa-Arango AC, Trevijano-Contador N, Román E, Sánchez-Fresneda R, Casas C, Herrero E, Argüelles JC, Pla J, Cuenca-Estrella M, Zaragoza O.

Antimicrob Agents Chemother. 2014 Nov;58(11):6627-38. doi: 10.1128/AAC.03570-14. Epub 2014 Aug 25.

19.

Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata.

Pankey G, Ashcraft D, Kahn H, Ismail A.

Antimicrob Agents Chemother. 2014 Oct;58(10):5795-800. doi: 10.1128/AAC.03035-14. Epub 2014 Jul 21.

20.

Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.

Rojas FD, Sosa Mde L, Fernández MS, Cattana ME, Córdoba SB, Giusiano GE.

Med Mycol. 2014 Aug;52(6):641-6. doi: 10.1093/mmy/myu010. Epub 2014 Jun 25.

PMID:
24965946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk